相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Miguel A. Sanz et al.
BLOOD (2009)
Improved Outcome of Acute Promyelocytic Leukemia With High WBC Counts Over the Last 15 Years: The European APL Group Experience
Charikleia Kelaidi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin
Farhad Ravandi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
Jiong Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy:: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group
Miguel A. Sanz et al.
BLOOD (2008)
Is cytarabine useful in the treatment of acute promyelocytic leukemia?: Results of a randomized trial from the European Acute Promyelocytic Leukemia Group
Lionel AdeS et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia
E Estey et al.
BLOOD (2006)
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity
V Mathews et al.
BLOOD (2006)
Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy
A Ghavamzadeh et al.
ANNALS OF ONCOLOGY (2006)
Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy:: a multicenter study by the PETHEMA group
MA Sanz et al.
BLOOD (2004)
Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia
MS Tallman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Effect of arsenic trioxide on QT interval in patients with advanced malignancies
JT Barbey et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)